Genvec Inc (NASDAQ:GNVC)

CAPS Rating: 1 out of 5

A biopharmaceutical company, which develops novel gene-based therapeutic drugs and vaccines.

Recs

0
Player Avatar pchop123 (78.33) Submitted: 1/8/2014 11:39:01 AM : Underperform Start Price: $2.71 GNVC Score: -9.70

priced beyond reality

Featured Broker Partners


Advertisement